Bank of New York Mellon’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.1M | Sell |
649,278
-141,805
| -18% | -$2.42M | ﹤0.01% | 1836 |
|
|
2025
Q1 | $50.5M | Sell |
791,083
-1,354,401
| -63% | -$86.4M | 0.01% | 958 |
|
|
2024
Q4 | $261M | Buy |
2,145,484
+26,581
| +1% | +$3.23M | 0.05% | 312 |
|
|
2024
Q3 | $265M | Sell |
2,118,903
-11,748
| -0.6% | -$1.47M | 0.05% | 315 |
|
|
2024
Q2 | $337M | Buy |
2,130,651
+63,614
| +3% | +$10.1M | 0.06% | 255 |
|
|
2024
Q1 | $268M | Sell |
2,067,037
-262,519
| -11% | -$34M | 0.05% | 309 |
|
|
2023
Q4 | $225M | Sell |
2,329,556
-181,811
| -7% | -$17.5M | 0.05% | 346 |
|
|
2023
Q3 | $304M | Buy |
2,511,367
+78,599
| +3% | +$9.53M | 0.07% | 266 |
|
|
2023
Q2 | $279M | Buy |
2,432,768
+518,050
| +27% | +$59.3M | 0.06% | 294 |
|
|
2023
Q1 | $264M | Sell |
1,914,718
-79,115
| -4% | -$10.9M | 0.06% | 301 |
|
|
2022
Q4 | $258M | Buy |
1,993,833
+110,835
| +6% | +$14.4M | 0.06% | 293 |
|
|
2022
Q3 | $208M | Sell |
1,882,998
-107,929
| -5% | -$11.9M | 0.05% | 343 |
|
|
2022
Q2 | $149M | Buy |
1,990,927
+16,104
| +0.8% | +$1.21M | 0.03% | 454 |
|
|
2022
Q1 | $154M | Sell |
1,974,823
-32,912
| -2% | -$2.57M | 0.03% | 495 |
|
|
2021
Q4 | $181M | Buy |
2,007,735
+49,770
| +3% | +$4.48M | 0.03% | 466 |
|
|
2021
Q3 | $181M | Sell |
1,957,965
-22,824
| -1% | -$2.11M | 0.04% | 444 |
|
|
2021
Q2 | $154M | Buy |
1,980,789
+189,495
| +11% | +$14.7M | 0.03% | 507 |
|
|
2021
Q1 | $134M | Buy |
1,791,294
+507,151
| +39% | +$37.8M | 0.03% | 564 |
|
|
2020
Q4 | $219M | Buy |
1,284,143
+12,811
| +1% | +$2.18M | 0.05% | 343 |
|
|
2020
Q3 | $179M | Sell |
1,271,332
-24,833
| -2% | -$3.49M | 0.04% | 373 |
|
|
2020
Q2 | $208M | Buy |
1,296,165
+159,776
| +14% | +$25.6M | 0.06% | 297 |
|
|
2020
Q1 | $111M | Sell |
1,136,389
-17,792
| -2% | -$1.74M | 0.04% | 427 |
|
|
2019
Q4 | $149M | Sell |
1,154,181
-33,444
| -3% | -$4.32M | 0.04% | 429 |
|
|
2019
Q3 | $89.5M | Buy |
1,187,625
+221,636
| +23% | +$16.7M | 0.02% | 633 |
|
|
2019
Q2 | $147M | Buy |
965,989
+109,743
| +13% | +$16.7M | 0.04% | 433 |
|
|
2019
Q1 | $102M | Buy |
856,246
+285,578
| +50% | +$34M | 0.03% | 572 |
|
|
2018
Q4 | $62.3M | Buy |
570,668
+291,823
| +105% | +$31.8M | 0.02% | 763 |
|
|
2018
Q3 | $45M | Buy |
278,845
+3,537
| +1% | +$571K | 0.01% | 1098 |
|
|
2018
Q2 | $36.4M | Sell |
275,308
-42,033
| -13% | -$5.56M | 0.01% | 1214 |
|
|
2018
Q1 | $23.5M | Sell |
317,341
-445
| -0.1% | -$33K | 0.01% | 1460 |
|
|
2017
Q4 | $17.7M | Buy |
317,786
+1,983
| +0.6% | +$110K | ﹤0.01% | 1646 |
|
|
2017
Q3 | $14.3M | Buy |
315,803
+57,592
| +22% | +$2.61M | ﹤0.01% | 1776 |
|
|
2017
Q2 | $8.7M | Buy |
258,211
+10,287
| +4% | +$347K | ﹤0.01% | 2051 |
|
|
2017
Q1 | $7.34M | Buy |
247,924
+1,923
| +0.8% | +$56.9K | ﹤0.01% | 2124 |
|
|
2016
Q4 | $6.75M | Buy |
246,001
+1,382
| +0.6% | +$37.9K | ﹤0.01% | 2168 |
|
|
2016
Q3 | $15M | Buy |
244,619
+22,801
| +10% | +$1.4M | ﹤0.01% | 1631 |
|
|
2016
Q2 | $4.23M | Buy |
221,818
+2,282
| +1% | +$43.5K | ﹤0.01% | 2291 |
|
|
2016
Q1 | $4.29M | Buy |
219,536
+1,403
| +0.6% | +$27.4K | ﹤0.01% | 2255 |
|
|
2015
Q4 | $8.42M | Buy |
218,133
+13,944
| +7% | +$538K | ﹤0.01% | 1935 |
|
|
2015
Q3 | $6.56M | Sell |
204,189
-37,288
| -15% | -$1.2M | ﹤0.01% | 2078 |
|
|
2015
Q2 | $7.35M | Buy |
241,477
+13,206
| +6% | +$402K | ﹤0.01% | 2119 |
|
|
2015
Q1 | $3.03M | Buy |
228,271
+19,670
| +9% | +$261K | ﹤0.01% | 2595 |
|
|
2014
Q4 | $3.02M | Sell |
208,601
-6,412
| -3% | -$92.8K | ﹤0.01% | 2587 |
|
|
2014
Q3 | $4.54M | Buy |
215,013
+14,064
| +7% | +$297K | ﹤0.01% | 2370 |
|
|
2014
Q2 | $5.99M | Sell |
200,949
-7,214
| -3% | -$215K | ﹤0.01% | 2220 |
|
|
2014
Q1 | $5M | Buy |
208,163
+29,870
| +17% | +$718K | ﹤0.01% | 2310 |
|
|
2013
Q4 | $3.63M | Buy |
178,293
+8,131
| +5% | +$166K | ﹤0.01% | 2494 |
|
|
2013
Q3 | $8.04M | Buy |
170,162
+4,104
| +2% | +$194K | ﹤0.01% | 1942 |
|
|
2013
Q2 | $6.32M | Buy |
+166,058
| New | +$6.32M | ﹤0.01% | 2052 |
|